UFP Technologies [UFPT] vs Abbott Laboratories [ABT] Detailed Stock Comparison
UFP Technologies
NASDAQ
Loading...
Abbott Laboratories
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: UFP Technologies wins in 7 metrics, Abbott Laboratories wins in 12 metrics, with 0 ties. Abbott Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | UFP Technologies | Abbott Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 25.19 | 16.53 | Abbott Laboratories |
| Price-to-Book Ratio | 4.35 | 4.53 | UFP Technologies |
| Debt-to-Equity Ratio | 46.98 | 26.50 | Abbott Laboratories |
| PEG Ratio | 0.97 | 0.45 | Abbott Laboratories |
| EV/EBITDA | 15.94 | 20.59 | UFP Technologies |
| Profit Margin (TTM) | 11.40% | 32.43% | Abbott Laboratories |
| Operating Margin (TTM) | 16.45% | 19.73% | Abbott Laboratories |
| EBITDA Margin (TTM) | 16.45% | 19.73% | Abbott Laboratories |
| Return on Equity | 19.29% | 30.93% | Abbott Laboratories |
| Return on Assets (TTM) | 11.53% | 6.62% | UFP Technologies |
| Free Cash Flow (TTM) | $56.94M | $6.35B | Abbott Laboratories |
| Dividend Yield | N/A | 1.28% | N/A |
| 1-Year Return | -34.79% | 17.14% | Abbott Laboratories |
| Price-to-Sales Ratio (TTM) | 2.85 | 5.32 | UFP Technologies |
| Enterprise Value | $1.84B | $235.76B | Abbott Laboratories |
| EV/Revenue Ratio | 3.13 | 5.47 | UFP Technologies |
| Gross Profit Margin (TTM) | 28.80% | 56.44% | Abbott Laboratories |
| Revenue per Share (TTM) | $77 | $25 | UFP Technologies |
| Earnings per Share (Diluted) | $8.63 | $7.97 | UFP Technologies |
| Beta (Stock Volatility) | 1.14 | 0.71 | Abbott Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
UFP Technologies vs Abbott Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| UFP Technologies | 0.08% | -1.98% | -3.21% | -4.21% | -13.75% | -10.83% |
| Abbott Laboratories | 0.45% | 2.10% | 6.09% | -0.79% | -2.16% | 16.36% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| UFP Technologies | -34.79% | 128.71% | 421.40% | 933.71% | 2,115.54% | 5,602.86% |
| Abbott Laboratories | 17.14% | 29.54% | 19.14% | 186.83% | 452.07% | 515.10% |
Performance & Financial Health Analysis: UFP Technologies vs Abbott Laboratories
| Metric | UFPT | ABT |
|---|---|---|
| Market Information | ||
| Market Cap | $1.68B | $229.31B |
| Market Cap Category | Small cap | Mega cap |
| 10 Day Avg. Volume | 131,250 | 6,185,250 |
| 90 Day Avg. Volume | 106,520 | 7,383,993 |
| Last Close | $219.56 | $132.60 |
| 52 Week Range | $178.26 - $366.41 | $110.86 - $141.23 |
| % from 52W High | -40.08% | -6.11% |
| All-Time High | $366.41 (Sep 23, 2024) | $142.60 (Dec 27, 2021) |
| % from All-Time High | -40.08% | -7.01% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.37% | 0.07% |
| Quarterly Earnings Growth | 0.27% | 0.37% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.32% |
| Operating Margin (TTM) | 0.16% | 0.20% |
| Return on Equity (TTM) | 0.19% | 0.31% |
| Debt to Equity (MRQ) | 46.98 | 26.50 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $49.99 | $29.05 |
| Cash per Share (MRQ) | $1.93 | $4.18 |
| Operating Cash Flow (TTM) | $83.37M | $9.04B |
| Levered Free Cash Flow (TTM) | $41.00M | $5.92B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.28% |
| Last 12-Month Dividend | N/A | $1.69 |
Valuation & Enterprise Metrics Analysis: UFP Technologies vs Abbott Laboratories
| Metric | UFPT | ABT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 25.19 | 16.53 |
| Forward P/E | 25.34 | 25.53 |
| PEG Ratio | 0.97 | 0.45 |
| Price to Sales (TTM) | 2.85 | 5.32 |
| Price to Book (MRQ) | 4.35 | 4.53 |
| Market Capitalization | ||
| Market Capitalization | $1.68B | $229.31B |
| Enterprise Value | $1.84B | $235.76B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.13 | 5.47 |
| Enterprise to EBITDA | 15.94 | 20.59 |
| Risk & Other Metrics | ||
| Beta | 1.14 | 0.71 |
| Book Value per Share (MRQ) | $49.99 | $29.05 |
Financial Statements Comparison: UFP Technologies vs Abbott Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | UFPT | ABT |
|---|---|---|
| Revenue/Sales | $151.18M | $10.36B |
| Cost of Goods Sold | $107.63M | $4.47B |
| Gross Profit | $43.54M | $5.89B |
| Research & Development | N/A | $716.00M |
| Operating Income (EBIT) | $24.86M | $1.69B |
| EBITDA | $29.55M | $2.66B |
| Pre-Tax Income | $21.63M | $1.78B |
| Income Tax | $4.45M | $453.00M |
| Net Income (Profit) | $17.18M | $1.33B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | UFPT | ABT |
|---|---|---|
| Cash & Equivalents | $14.03M | $6.53B |
| Total Current Assets | $205.89M | $23.15B |
| Total Current Liabilities | $79.87M | $13.00B |
| Long-Term Debt | $181.92M | $12.74B |
| Total Shareholders Equity | $360.67M | $49.06B |
| Retained Earnings | $323.69M | $47.72B |
| Property, Plant & Equipment | $15.26M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | UFPT | ABT |
|---|---|---|
| Operating Cash Flow | $14.76M | $1.42B |
| Capital Expenditures | $-2.82M | $-484.00M |
| Free Cash Flow | $10.99M | $933.00M |
| Debt Repayment | $-15.64M | $-1.00B |
| Common Stock Repurchase | N/A | $-280.00M |
Short Interest & Institutional Ownership Analysis
| Metric | UFPT | ABT |
|---|---|---|
| Shares Short | 1.39M | 18.33M |
| Short Ratio | 15.31 | 2.44 |
| Short % of Float | 0.22% | 0.01% |
| Average Daily Volume (10 Day) | 131,250 | 6,185,250 |
| Average Daily Volume (90 Day) | 106,520 | 7,383,993 |
| Shares Outstanding | 7.68M | 1.73B |
| Float Shares | 7.42M | 1.73B |
| % Held by Insiders | 0.04% | 0.01% |
| % Held by Institutions | 1.19% | 0.81% |
Dividend Analysis & Yield Comparison: UFP Technologies vs Abbott Laboratories
| Metric | UFPT | ABT |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.69 |
| Last 12-Month Dividend Yield | N/A | 1.28% |
| 3-Year Avg Annual Dividend | N/A | $1.92 |
| 3-Year Avg Dividend Yield | N/A | 0.49% |
| 3-Year Total Dividends | N/A | $5.77 |
| Ex-Dividend Date | N/A | Jan 15, 2025 |